Identification of Sanguinarine as a Novel HIV Protease Inhibitor from High-Throughput Screening of 2,000 Drugs and Natural Products with a Cell-Based Assay

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|2|5|364-371

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.2, Iss.5, 2005-08, pp. : 364-371

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of a cell-based high-throughput peroxisome proliferator-activated receptors (PPARs) screening model and its application for evaluation of the extracts from Rhizoma Coptis

By Xia Zhi-Ning  

Journal of Asian Natural Products Research, Vol. 15, Iss. 3, 2013-03 ,pp. : 225-234

Taylor & Francis Ltd

Access to resources Recommend Favorite

High‐throughput screening (HTS) for the identification of novel antiviral scaffolds

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 79-83

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of a Scintillation Proximity Assay (SPA) Based, High Throughput Screening Feasible Method for the Identification of PDE12 Activity Modulators

By  

Current Drug Discovery Technologies, Vol. 13, Iss. 3, 2016-10 ,pp. : 144-151

Bentham Science Publishers

Access to resources Recommend Favorite

How can high-throughput screening deliver drugs to treat atherosclerosis?

By Yang Yuan   Wang Li   Si Shuyi   Hong Bin  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 12, 2010-12 ,pp. : 1175-1188

Informa Healthcare

Access to resources Recommend Favorite

Review of HIV-1 Protease Inhibitor Assay Methods

By  

Current Pharmaceutical Analysis, Vol. 3, Iss. 3, 2007-08 ,pp. : 180-185

Bentham Science Publishers

Access to resources Recommend Favorite